Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: immunotherapy


By including independent viewpoints, STAT takes a more measured approach to coverage of brain cancer immunotherapy


With no independent sources, TIME oversells brain cancer treatment


Reuters’ ‘New day in lung cancer’ presents overly rosy picture of Keytruda


Experimental immunotherapy for kids with leukemia gets balanced coverage by Washington Post

1 6/15/2016

Scientist’s quest to fight cancer: Captivating story from NPR overlooked limitations


Except for presidential anecdote, NBC story on new melanoma drug was well-balanced


Philly physician Q&A hits many key points on newer allergy treatments


Coverage of virus-based cancer treatment skimps on cautions and key outcomes


With focus on one patient, story manages to convey complexity of T-cell therapy for leukemia


Story on new melanoma drug combo neglects to mention $250,000 price tag